DK1469859T3 - Anvendelse af flerumættede ketoner til behandling af psoriasis - Google Patents
Anvendelse af flerumættede ketoner til behandling af psoriasisInfo
- Publication number
- DK1469859T3 DK1469859T3 DK03704739.6T DK03704739T DK1469859T3 DK 1469859 T3 DK1469859 T3 DK 1469859T3 DK 03704739 T DK03704739 T DK 03704739T DK 1469859 T3 DK1469859 T3 DK 1469859T3
- Authority
- DK
- Denmark
- Prior art keywords
- psoriasis
- treatment
- group
- hydrocarbon group
- polyunsaturated ketones
- Prior art date
Links
- 201000004681 Psoriasis Diseases 0.000 title abstract 3
- 150000002576 ketones Chemical class 0.000 title 1
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000006575 electron-withdrawing group Chemical group 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0202002.2A GB0202002D0 (en) | 2002-01-29 | 2002-01-29 | Use |
| PCT/GB2003/000364 WO2003063878A1 (en) | 2002-01-29 | 2003-01-29 | Use of polyunsaturated ketones for the treatment of psoriasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1469859T3 true DK1469859T3 (da) | 2012-03-19 |
Family
ID=9929945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03704739.6T DK1469859T3 (da) | 2002-01-29 | 2003-01-29 | Anvendelse af flerumættede ketoner til behandling af psoriasis |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US7687543B2 (da) |
| EP (1) | EP1469859B1 (da) |
| JP (1) | JP4608214B2 (da) |
| KR (1) | KR100874505B1 (da) |
| CN (2) | CN101849929A (da) |
| AT (1) | ATE535245T1 (da) |
| AU (1) | AU2003206999B2 (da) |
| CA (1) | CA2473687C (da) |
| DK (1) | DK1469859T3 (da) |
| ES (1) | ES2378303T3 (da) |
| GB (1) | GB0202002D0 (da) |
| NO (1) | NO334413B1 (da) |
| PT (1) | PT1469859E (da) |
| WO (1) | WO2003063878A1 (da) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2248798A1 (en) * | 2009-05-08 | 2010-11-10 | Pronova BioPharma Norge AS | Novel lipid compounds |
| GB0909643D0 (en) * | 2009-06-04 | 2009-07-22 | Avexxin As | Glomerulonephritis treatment |
| JP6012468B2 (ja) * | 2009-10-02 | 2016-10-25 | アヴェクシン エーエス | 抗炎症性２−オキソチアゾールおよび２−オキソオキサゾール |
| GB201014633D0 (en) * | 2010-09-02 | 2010-10-13 | Avexxin As | Rheumatoid arthritis treatment |
| ES2618604T3 (es) | 2010-11-05 | 2017-06-21 | Pronova Biopharma Norge As | Métodos de tratamiento usando compuestos lipídicos |
| GB201205394D0 (en) | 2012-03-27 | 2012-05-09 | Adlens Ltd | Improvements in or relating to deformable non-round membrane assemblies |
| GB201221329D0 (en) | 2012-11-27 | 2013-01-09 | Avexxin As | Dermatitis treatment |
| JP6371312B2 (ja) | 2013-01-29 | 2018-08-08 | アヴェクシン エーエス | 坑炎症および抗腫瘍２−オキソチアゾール化合物ならびに２−オキソチオフェン化合物 |
| KR102213143B1 (ko) | 2013-02-28 | 2021-02-08 | 바스프 에이에스 | 지방질 화합물, 트리글리세리드 및 계면활성제를 포함하는 조성물 및 이를 이용하는 방법 |
| GB201313238D0 (en) | 2013-07-24 | 2013-09-04 | Avexxin As | Process for the preparation of a polyunsaturated ketone compound |
| GB201409363D0 (en) * | 2014-05-27 | 2014-07-09 | Avexxin As | Skin cancer treatment |
| GB201413695D0 (en) | 2014-08-01 | 2014-09-17 | Avexxin As | Compound |
| GB201501144D0 (en) | 2015-01-23 | 2015-03-11 | Avexxin As | Process for the preparation of a polyunsaturated ketone compound |
| KR102644400B1 (ko) | 2015-04-28 | 2024-03-06 | 바스프 에이에스 | 비알코올성 지방간염의 예방 및/또는 치료를 위한 구조적으로 강화된 함황 지방산의 용도 |
| GB201604316D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
| GB201604318D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
| CA3025698A1 (en) * | 2016-06-03 | 2017-12-07 | Avexxin As | Combination therapy comprising a polyunsaturated ketone and a calcineurin inhibitor |
| GB201609735D0 (en) * | 2016-06-03 | 2016-07-20 | Avexxin As | Combination therapy |
| EP3463471A1 (en) * | 2016-06-03 | 2019-04-10 | Avexxin AS | Combination therapy comprising a polyunsaturated ketone and a secosteroid |
| CN109310771A (zh) * | 2016-06-03 | 2019-02-05 | 埃维克辛公司 | 包含多不饱和酮与皮质甾类化合物的联合疗法 |
| WO2018055062A1 (en) | 2016-09-21 | 2018-03-29 | Avexxin As | Pharmaceutical composition |
| ES2896686T3 (es) * | 2017-06-16 | 2022-02-25 | Avexxin As | Composiciones y métodos para el tratamiento de una enfermedad fibrótica |
| US11925614B2 (en) | 2017-12-06 | 2024-03-12 | Basf As | Fatty acid derivatives for treating non-alcoholic steatohepatitis |
| GB201807892D0 (en) | 2018-05-15 | 2018-06-27 | Avexxin As | Processes in the preparation of polyunsaturated ketone compounds |
| GB202020843D0 (en) | 2020-12-31 | 2021-02-17 | Coegin Pharma Ab | Actinic keratosis treatment |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09268153A (ja) | 1996-04-02 | 1997-10-14 | Sagami Chem Res Center | トリフルオロメチルケトン誘導体及びホスホリパーゼａ２阻害剤 |
| EP1140791A2 (en) * | 1997-09-23 | 2001-10-10 | Bristol-Myers Squibb Company | Selective cpla 2 inhibitors |
| JPH11199493A (ja) * | 1997-11-13 | 1999-07-27 | Nof Corp | 皮膚外用剤組成物 |
| AU4994899A (en) * | 1998-07-13 | 2000-02-01 | University Of South Florida | Modulation of the phospholipase a2 pathway as a therapeutic |
| WO2002060535A1 (en) * | 2001-01-31 | 2002-08-08 | Leff Alan R | Method of treating inflammatory conditions by inhibiting cytosolic phospholipase a¿2? |
| EP1243524A3 (en) * | 2001-03-16 | 2004-04-07 | Pfizer Products Inc. | Pharmaceutical kit for oxygen-sensitive drugs |
| US20040111957A1 (en) * | 2002-12-13 | 2004-06-17 | Filippini Brian B. | Water blended fuel composition |
-
2002
- 2002-01-29 GB GBGB0202002.2A patent/GB0202002D0/en not_active Ceased
-
2003
- 2003-01-29 CN CN201010129984A patent/CN101849929A/zh active Pending
- 2003-01-29 CA CA2473687A patent/CA2473687C/en not_active Expired - Fee Related
- 2003-01-29 CN CNA038028999A patent/CN1678323A/zh active Pending
- 2003-01-29 EP EP03704739A patent/EP1469859B1/en not_active Expired - Lifetime
- 2003-01-29 US US10/502,414 patent/US7687543B2/en not_active Expired - Fee Related
- 2003-01-29 AT AT03704739T patent/ATE535245T1/de active
- 2003-01-29 DK DK03704739.6T patent/DK1469859T3/da active
- 2003-01-29 ES ES03704739T patent/ES2378303T3/es not_active Expired - Lifetime
- 2003-01-29 KR KR1020047011693A patent/KR100874505B1/ko not_active Expired - Fee Related
- 2003-01-29 JP JP2003563568A patent/JP4608214B2/ja not_active Expired - Fee Related
- 2003-01-29 AU AU2003206999A patent/AU2003206999B2/en not_active Ceased
- 2003-01-29 WO PCT/GB2003/000364 patent/WO2003063878A1/en not_active Ceased
- 2003-01-29 PT PT03704739T patent/PT1469859E/pt unknown
-
2004
- 2004-08-25 NO NO20043548A patent/NO334413B1/no not_active IP Right Cessation
-
2010
- 2010-02-26 US US12/713,917 patent/US8524776B2/en not_active Expired - Fee Related
-
2013
- 2013-08-02 US US13/957,899 patent/US8865768B2/en not_active Expired - Lifetime
-
2014
- 2014-09-16 US US14/487,382 patent/US9375409B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US8865768B2 (en) | 2014-10-21 |
| KR100874505B1 (ko) | 2008-12-18 |
| CA2473687A1 (en) | 2003-08-07 |
| CA2473687C (en) | 2011-04-12 |
| NO20043548L (no) | 2004-08-25 |
| EP1469859A1 (en) | 2004-10-27 |
| WO2003063878A1 (en) | 2003-08-07 |
| US20050165116A1 (en) | 2005-07-28 |
| ES2378303T3 (es) | 2012-04-11 |
| US20130324613A1 (en) | 2013-12-05 |
| US20100152293A1 (en) | 2010-06-17 |
| KR20040089127A (ko) | 2004-10-20 |
| US20150202165A1 (en) | 2015-07-23 |
| US9375409B2 (en) | 2016-06-28 |
| GB0202002D0 (en) | 2002-03-13 |
| CN101849929A (zh) | 2010-10-06 |
| PT1469859E (pt) | 2012-03-06 |
| JP4608214B2 (ja) | 2011-01-12 |
| NO334413B1 (no) | 2014-02-24 |
| AU2003206999B2 (en) | 2007-12-13 |
| ATE535245T1 (de) | 2011-12-15 |
| US8524776B2 (en) | 2013-09-03 |
| US7687543B2 (en) | 2010-03-30 |
| CN1678323A (zh) | 2005-10-05 |
| EP1469859B1 (en) | 2011-11-30 |
| JP2005518419A (ja) | 2005-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1469859T3 (da) | Anvendelse af flerumættede ketoner til behandling af psoriasis | |
| SE0301886D0 (sv) | New use V | |
| SE0301888D0 (sv) | New use VII | |
| DE60231804D1 (de) | Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomöostase störungen | |
| DK1651161T3 (da) | Farmaceutiske præparater og fremgangsmåder til at fremme sårheling | |
| ATE440094T1 (de) | Fumagillolderivate und verfahren zu deren herstellung | |
| ATE539751T1 (de) | Verwendung von brimonidine zur behandlung von stress assoziierten zuständen | |
| MY147643A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder | |
| EP1505990A4 (en) | METHOD FOR THE TREATMENT OF HEPATITIS | |
| ATE452884T1 (de) | Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase | |
| CY1109763T1 (el) | Υλικα και μεθοδος για τη θεραπεια διαταραχων πηξης | |
| NO20025510D0 (no) | Tienodibenzoazulenforbindelser som tumor nekrose faktor inhibitorer | |
| DK1648484T3 (da) | Fremgangsmåde til behandling af arthritis-tilstande | |
| DE59914712D1 (de) | Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden | |
| ATE469886T1 (de) | 17beta-hydroxysteroid dehydrogenase typ-3 hemmer zur behandlung von androgen abhängigen erkrankungen | |
| DE60329326D1 (de) | Tace inhibitoren | |
| DE60011794D1 (de) | Verwendung von docetaxel für die behandlung von hepatozelluläre krebs | |
| SE0301885D0 (sv) | New use IV | |
| RU2007138263A (ru) | Противовоспалительные соединения | |
| DE69324374D1 (de) | Verwendung von kardiotonischen Mitteln und Inhibitoren der Stickstoffoxidsynthese zur Linderung von pathologisch verringertem Blutdruck | |
| SE0301884D0 (sv) | New use III | |
| CY1107756T1 (el) | Αναλογα θειου της 21-υδροξυ-6, 19-οξειδοπρογεστερονης (21oh-6οp) για τη θεραπεια πλεονασματος γλυκοκορτικοειδων | |
| WO2003094967A3 (en) | New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders | |
| DK1455770T3 (da) | Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser | |
| WO2006002763A3 (de) | Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament |